Probuphine
FDA Approves First Buprenorphine Implant To Treat Opioid Dependence
The FDA approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence.
JUNE 1, 2016
FDA Advisory Committee Recommends Approval of Buprenorphine Implant for Opioid Addiction
Probuphine can provide up to six months of sustained delivery of the opioid partial agonist buprenorphine when four ...
JANUARY 14, 2016
Load more